MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Pasithea Therapeutics Corp. (KTTA)

Pasithea Therapeutics Corp. (KTTA)

|||

Balance Sheets Overview

Current Ratio
2624.93%
Quick Ratio
2624.93%
Cash Ratio
2484.54%
Debt to Asset Ratio
3.62%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Prepaid expenses
    • Restricted cash
    • Other current assets
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable and accrued lia...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
45,663,782
50,400,377
55,158,939
4,122,953
Restricted cash
101,317
101,090
100,866
100,599
Prepaid expenses
2,456,401
1,829,519
811,456
1,286,009
Other current assets
22,541
400,470
387,823
19,665
Total current assets
48,244,041
52,731,456
56,459,084
5,529,226
Intangibles, net
-
-
-
6,838,527
Goodwill
-
-
-
1,262,911
Intangibles, net
3,465,904
3,623,445
3,780,986
-
Total assets
51,709,945
56,354,901
60,240,070
13,630,664
Accounts payable and accrued liabilities
1,837,917
1,489,485
1,131,104
1,337,801
Financed director and officer insurance premiums
-
-
-
39,310
Warrant liabilities placement agent warrants
-
-
3,842,857
-
Total current liabilities
1,837,917
1,489,485
4,973,961
1,377,111
Warrant liabilities
-
-
-
46,871
Warrant liabilities - representative warrants
32,341
52,966
46,871
-
Total non-current liabilities
32,341
52,966
46,871
46,871
Total liabilities
1,870,258
1,542,451
5,020,832
1,423,982
Common stock, par value 0.0001 per share, 500,000,000 shares authorized 33,414,448 shares and 23,091,062 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
3,341
2,494
2,309
743
Additional paid-in capital
127,980,571
127,643,001
125,208,624
72,087,231
Accumulated other comprehensive income
9,570
46,898
18,766
18,301
Accumulated deficit
-78,153,795
-72,879,943
-70,010,461
-59,899,593
Total stockholders equity
49,839,687
54,812,450
55,219,238
12,206,682
Total liabilities and stockholders equity
51,709,945
56,354,901
60,240,070
13,630,664
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$45,663,782 (532.72%↑ Y/Y)Prepaid expenses$2,456,401 (88.71%↑ Y/Y)Restricted cash$101,317 Other current assets$22,541 (-80.87%↓ Y/Y)Total current assets$48,244,041 (458.60%↑ Y/Y)Intangibles, net$3,465,904 (-50.46%↓ Y/Y)Total assets$51,709,945 (204.01%↑ Y/Y)Total liabilities andstockholders equity$51,709,945 (204.01%↑ Y/Y)Total stockholdersequity$49,839,687 (228.36%↑ Y/Y)Total liabilities$1,870,258 (2.16%↑ Y/Y)Accumulated deficit-$78,153,795 (-37.44%↓ Y/Y)Additional paid-in capital$127,980,571 (77.67%↑ Y/Y)Total currentliabilities$1,837,917 (5.81%↑ Y/Y)Total non-currentliabilities$32,341 (-65.50%↓ Y/Y)Accumulated othercomprehensive income$9,570 (69.95%↑ Y/Y)Common stock, par value0.0001 per share,...$3,341 (349.66%↑ Y/Y)Accounts payable andaccrued liabilities$1,837,917 (16.21%↑ Y/Y)Warrant liabilities -representative warrants$32,341